Skip to main content
Erschienen in: Medical Oncology 1/2012

01.03.2012 | Original Paper

Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer

verfasst von: Kaixiong Tao, Chuanqing Wu, Ke Wu, Wei Li, Gaoxiong Han, Xiaoming Shuai, Guobin Wang

Erschienen in: Medical Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Hypermethylation has been shown in the promoter region of the endothelin receptor B (EDNRB) gene in several human tumors. However, its role in gastric cancer formation is still unclear. In this study, the methylation status of the EDNRB gene in paired gastric cancer tissues and adjacent normal tissues from 96 patients was detected quantitatively using pyrosequencing. The results showed the methylation of promoter of EDNRB gene in gastric cancer (50.42 ± 9.03%) was significantly higher than in adjacent normal tissues (6.47 ± 2.98%) (P < 0.01). Among 96 tumor tissues, promoter hypermethylation of the EDNRB gene was correlated with tumor infiltration (T1: 47.4 ± 7.31% T2:48.2 ± 9.17% T3:52.9 ± 6.48% T4:53.2 ± 10.45%), lymph node metastasis (N0:45.4 ± 6.99% N1:49.0 ± 9.10% N2:52.0 ± 8.40% N3:53.7 ± 9.92%), and distant metastasis (M0:48.9 ± 6.99% M1:53.9 ± 11.98%) (P < 0.05), but it was not associated with other clinicopathological characteristics. In addition, the treatment of the human gastric cancer cell line, SGC-7901, with demethylation agent can restore the expression of EDNRB. Our results suggest that promoter hypermethylation of EDNRB gene is highly prevalent in gastric cancer, which may play a role in the pathogenesis of gastric cancer. Futhermore, hypermethylation of EDNRB gene was remarkably related to infiltration and metastasis of gastric cancer and may attribute to the tumor progression.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002 CA Cancer. J Clin. 2005;55(2):74–108. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002 CA Cancer. J Clin. 2005;55(2):74–108.
2.
Zurück zum Zitat Yu M, Zheng HC, Xia P, Takahashi H, Masuda S. Takano Y and Xu HM: Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res. 2010;132:295–302.PubMed Yu M, Zheng HC, Xia P, Takahashi H, Masuda S. Takano Y and Xu HM: Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan. Indian J Med Res. 2010;132:295–302.PubMed
3.
Zurück zum Zitat Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293:1068–70.PubMedCrossRef Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293:1068–70.PubMedCrossRef
4.
Zurück zum Zitat Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003;4:351–8.PubMedCrossRef Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003;4:351–8.PubMedCrossRef
5.
Zurück zum Zitat Kikuchi R, Tsuda H, Kanai Y, et al. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 2007;67:7095–105.PubMedCrossRef Kikuchi R, Tsuda H, Kanai Y, et al. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer. Cancer Res. 2007;67:7095–105.PubMedCrossRef
6.
7.
Zurück zum Zitat Baylin SB, Herman JR, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation : a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–96.PubMedCrossRef Baylin SB, Herman JR, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation : a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–96.PubMedCrossRef
8.
Zurück zum Zitat Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999;59:1090–5.PubMed Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999;59:1090–5.PubMed
9.
Zurück zum Zitat Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncology. 2001;20:1525–8. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncology. 2001;20:1525–8.
10.
Zurück zum Zitat Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61(8):3225–9.PubMed Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001;61(8):3225–9.PubMed
11.
Zurück zum Zitat Buffart TE, Overmeer RM, Steenbergen RD, et al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer. 2008;99:1802–7.PubMedCrossRef Buffart TE, Overmeer RM, Steenbergen RD, et al. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br J Cancer. 2008;99:1802–7.PubMedCrossRef
12.
Zurück zum Zitat Pla P, Larue L. Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol. 2003;47:315–25.PubMed Pla P, Larue L. Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol. 2003;47:315–25.PubMed
13.
Zurück zum Zitat Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell. 1994;79:1257–66.PubMedCrossRef Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell. 1994;79:1257–66.PubMedCrossRef
14.
Zurück zum Zitat Pao MM, Tsutsumi M, Liang G, et al. The endothelin receptor B promoter displays heterogenous, site special methylation patterns in normal and tumor cells. Hum Mol Genet. 2001;10:903–10.PubMedCrossRef Pao MM, Tsutsumi M, Liang G, et al. The endothelin receptor B promoter displays heterogenous, site special methylation patterns in normal and tumor cells. Hum Mol Genet. 2001;10:903–10.PubMedCrossRef
15.
Zurück zum Zitat Yang AS, Doshi KD, Choi SW, et al. DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res. 2006;66(10):5495–503.PubMedCrossRef Yang AS, Doshi KD, Choi SW, et al. DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res. 2006;66(10):5495–503.PubMedCrossRef
16.
Zurück zum Zitat Lo KW, Tsang YS, Kwong J, et al. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer. 2002;98:651–5.PubMedCrossRef Lo KW, Tsang YS, Kwong J, et al. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer. 2002;98:651–5.PubMedCrossRef
17.
Zurück zum Zitat Jeronimo C, Henrique R, Campos PF, et al. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Patho. 2003;56:52–5.CrossRef Jeronimo C, Henrique R, Campos PF, et al. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Patho. 2003;56:52–5.CrossRef
18.
Zurück zum Zitat Eberle J, Weitmann S, Thieck O, et al. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermoatol. 1999;112:925–32.CrossRef Eberle J, Weitmann S, Thieck O, et al. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermoatol. 1999;112:925–32.CrossRef
19.
Zurück zum Zitat Chen SC, Lin CY, Chen YH, et al. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan. Oncol Rep. 2006;15:167–82.PubMed Chen SC, Lin CY, Chen YH, et al. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan. Oncol Rep. 2006;15:167–82.PubMed
20.
Zurück zum Zitat Zhao BJ, Sun DG, Zhang M, et al. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus. 2009;22(1):55–61.PubMedCrossRef Zhao BJ, Sun DG, Zhang M, et al. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus. 2009;22(1):55–61.PubMedCrossRef
21.
Zurück zum Zitat Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nature Rev. 2006;7:21–33.CrossRef Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nature Rev. 2006;7:21–33.CrossRef
22.
Zurück zum Zitat Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005;5:223–31.PubMedCrossRef Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer. 2005;5:223–31.PubMedCrossRef
23.
Zurück zum Zitat Hsu LS, Lee HC, Chau GY, et al. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep. 2006;15:507–11.PubMed Hsu LS, Lee HC, Chau GY, et al. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep. 2006;15:507–11.PubMed
24.
Zurück zum Zitat Pflug BR, Zheng H, Udan MS, et al. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Lett. 2007;246:139–48.PubMedCrossRef Pflug BR, Zheng H, Udan MS, et al. Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor. Cancer Lett. 2007;246:139–48.PubMedCrossRef
25.
Zurück zum Zitat Jha AK, Nikbakht M, Parashar G, et al. Reversal of hypermethylation and reactivation of the rarβ2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha). 2010;56(5):195–200. Jha AK, Nikbakht M, Parashar G, et al. Reversal of hypermethylation and reactivation of the rarβ2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha). 2010;56(5):195–200.
26.
Zurück zum Zitat Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004;64:1975–86.PubMedCrossRef Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004;64:1975–86.PubMedCrossRef
Metadaten
Titel
Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer
verfasst von
Kaixiong Tao
Chuanqing Wu
Ke Wu
Wei Li
Gaoxiong Han
Xiaoming Shuai
Guobin Wang
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9805-8

Weitere Artikel der Ausgabe 1/2012

Medical Oncology 1/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.